Dr. Michael D. Fox, MD , is a reproductive endocrinologist with expertise in nutritional treatment to improve fertility based in Jacksonville, Florida, USA.
Dr. Fox has extensive experience in using strict low-carb diets and other lifestyle interventions – combined with medication, if necessary – to maximize the chances of getting pregnant, and for treating PCOS . He’s also knowledgeable in other aspects of women’s health.
While the importance of nutrition during pregnancy is widely known, Dr. Fox believes that diet likewise plays a significant role in the ability to become pregnant.
He is the founder and medical director of Jacksonville Center for Reproductive Medicine . Together with his colleagues, he aims to help couples achieve pregnancy using a less invasive and more natural approach as much as possible. Additionally, he is an assistant professor and teaches obstetrics and gynecology residents at the University of Florida .
He has written chapters in numerous OB-GYN and reproductive endocrinology publications having to do with topics such as endometriosis, treatment of female infertility, and treatment of male associated infertility. Professional organizations of which Dr. Fox is a member include the American Society for Reproductive Medicine, the American College of Obstetricians and Gynecologists and several others.
Dr. Fox received a pre-medical degree in biology from Auburn University and his MD from the University of Alabama at Birmingham . After completing his residency in obstetrics and gynecology at the University of Mississippi , he was granted a two-year fellowship at the University of Kentucky in reproductive endocrinology and infertility. He is board-certified both in obstetrics and gynecology and reproductive endocrinology and infertility .
Select scientific publications
Fox MD, Hyde JF, Muse KN, Keeble SC, Howard G, London SN, Curry TE. Galinin: A novel intraovarian regulatory peptide . Endocrinol 135 : 636-641, 1994.
Fox MD , Allbert JR, McCaul JF, Martin RW, McLaughlin BN, Morrison JC. Neonatal Morbidity Between 34 and 37 Weeks’ Gestation . Obstet & Gyn Surv: 1994.
Tobar Hicks AB , Fox M D, Sanchez-Ramos L, Kaunitz AM, Freeman MF. Clinical characteristics of patients with an abnormal clomiphene citrate challenge test . Am J Obstet Gynecol. 2003 Aug; 189(2): 348-52.
Dr. Michael Fox on Diet Doctor
For DD members only, you can learn more about Dr. Fox’s approach to reproductive medicine by tuning into Ask Dr. Fox.
More videos
